Related Experiment Video
Updated: Sep 20, 2026

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions
Published on: January 18, 2016
Absence of the transcription factor E2F1 attenuates brain injury and improves behavior after focal ischemia in mice
John P MacManus1, Ming Jian, Edward Preston
1Institute for Biological Sciences, National Research Council of Canada, Ottawa, Canada. John.MacManus@NRC.CA
Abstract:
Because of observations that cultured neurons from mice deficient in the transcription factor E2F1 exhibit resistance after treatment with a wide variety of cell-death inducers, the authors investigated whether resistance extended to a cerebral ischemic insult. No differences in cerebral blood flow or physiologic parameters were observed in the mutant E2F1 littermates after the focal ligation. After 2 hours of left middle cerebral artery occlusion and 1 day of reperfusion, a 33% smaller infarct (P < 0.05) was observed by 2,3,5-triphenyltetrazolium staining in the brains of E2F1-null mice compared with their E2F1+/+ and +/- littermates. A milder ischemic insult produced by 20 minutes of middle cerebral artery occlusion and 7 days of reperfusion produced a greater difference in the E2F1-null animals with a 71% smaller infarct (P < 0.001) compared to littermate controls. A decrease in neuronal damage after mild ischemia in E2F1-null mice was observed by immunohistochemical monitoring of the loss in neuronal-specific microtubule-associated protein 2 cytoskeletal protein and the appearance of nuclear DNA fragmentation by terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate-biotin nick end labeling. This decreased brain damage was evidenced by improved behavior in motor function of E2F1 -/- mice compared with their E2F1 +/+ littermates by 7 days of reperfusion. In an effort to address the underlying molecular mechanism of the resistance of E2F1-null mice, the expression of several downstream proapoptotic target genes (p73, Apaf1, Arf) of the E2F1 transcription factor was measured by quantitative polymerase chain reaction. Although an attenuated increase in Hsp68 mRNA was found in E2F1 -/- mice, no changes in the proapoptotic transcripts were found after ischemia, and a mechanistic inference was not possible. The authors conclude that the transcription factor E2F1 does modulate neuronal viability in brain after cerebral ischemia and corroborates the findings with cultured neurons.
Insights
Mice lacking the transcription factor E2F1 showed significantly reduced brain damage and improved motor function following ischemic stroke. This suggests E2F1 plays a role in neuronal cell death after cerebral ischemia.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Cultured neurons lacking the transcription factor E2F1 (E2F1-null) display resistance to cell death inducers.
- This resistance suggests a potential role for E2F1 in neuronal vulnerability to injury.
Purpose of the Study:
- To investigate if E2F1 deficiency confers resistance to cerebral ischemic injury in vivo.
- To determine the impact of E2F1 on neuronal damage and functional recovery after stroke.
Main Methods:
- Cerebral ischemia was induced in E2F1-null mice and littermate controls using middle cerebral artery occlusion.
- Infarct volume was quantified using 2,3,5-triphenyltetrazolium staining.
- Neuronal damage was assessed via immunohistochemistry for microtubule-associated protein 2 and DNA fragmentation (TUNEL assay).
- Behavioral tests evaluated motor function recovery.
- Quantitative polymerase chain reaction measured the expression of E2F1 target genes.
Main Results:
- E2F1-null mice exhibited significantly smaller infarct volumes (33-71% reduction) after varying durations of ischemia compared to controls.
- Reduced neuronal damage and DNA fragmentation were observed in E2F1-null mice.
- E2F1-null mice demonstrated improved motor function recovery post-stroke.
- No significant changes in key pro-apoptotic gene expression were detected, hindering mechanistic inference.
Conclusions:
- The transcription factor E2F1 modulates neuronal viability in the brain following cerebral ischemia.
- E2F1 deficiency confers neuroprotection against ischemic stroke, corroborating in vitro findings.

